HEALTH

At-home liver damage test now available in the U.K.

BY Michael Johnsen

LONDON Livercheck.com.uk on Tuesday announced the U.K. launch of a liver blood at-home test “to throw a vital lifeline to the millions of [British] drinkers who are potentially at risk from liver disease.”

LiverCheck is the first home blood-liver test available in the U.K., and aims to identify liver damage resulting from excessive consumption of alcohol.

“There is little doubt in my mind that it has the potential to save lives,” stated Rajiv Jalan of the University College London. “If someone knew their liver was damaged and likely to get worse, they would do something about it. Checking the health of the liver could avoid them getting to the stage where they are doing themselves real harm without knowing about it.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

HEALTH

SinoFresh signs leter-of-intent with National Starch and Chemical

BY DSN STAFF

ENGLEWOOD, Fla. SinoFresh HealthCare earlier this week announced its non-binding letter-of-intent signed with National Starch and Chemical Co. to develop new versions of popular allergy-related over-the-counter medicines.

The company is targeting March 2008 for launch. 

The new products will utilize National Starch’s proprietary patented Proloc bio-adhesive technology to deliver the drug formulations. 

“In the United States, our current nasal spray has been aimed at helping the 37 million people who suffer from Chronic Sinusitis. By developing new and improved allergy-related formulations, we expect to help an additional 50 million people who suffer from allergies,” stated SinoFresh chief executive officer Charles Fust.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

HEALTH

Novartis introduces Canada’s Buckley’s cough medicine to U.S. market

BY Michael Johnsen

PARSIPPANY, N.J. Novartis is bringing Buckley’s, Canada’s No. 1 cough product—according to Information Resources, Inc. data for the 52 weeks ended Aug. 4—to the U.S. market. The brand will be introduced with two SKUs: a cough suppressant mixture and a chest congestion mixture that includes an expectorant.

Buckley’s point of differentiation is its bad taste with the slogan “It tastes awful. And it works.” The cough syrup is both sugar- and alcohol-free and includes camphor, Canadian fir balsam gum, pine needle oil and menthol.

To help generate interest in its U.S. debut, Novartis is sponsoring an online photo contest that invites people to post images of themselves tasting Buckley’s. The contest kicks off Nov. 5 and runs for one month. Entrants will have a chance to win an Alaskan Adventure vacation for two.

“There are two kinds of people in this world—those who what comfort when they are sick and those who want to get better,” stated Jose Rodriguez, Novartis Consumer Health vice president of marketing. “Buckley’s is for people who are focused on getting back to feeling like themsevels again quickly.”

According to Novartis, 65 percent of U.S. households purchased a cough remedy in the last year.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES